EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Precision Medicine for Peritoneal Carcinomatosis—Current Advances in Organoid Drug Testing and Clinical Applicability

Harleen Kaur, Josephine A. Wright, Daniel L. Worthley, Elizabeth Murphy, Susan L. Woods

Organoids · 24.01.2025 · 4 (1) · 2

DOI: 10.3390/organoids4010002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organoids, online erschienen am 24.01.2025. Verfasst von Harleen Kaur und 4 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tour de Cure.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peritoneal carcinomatosis from gastrointestinal tumours is considered a poor prognostic factor, with a median overall survival of six to nine months in the absence of intervention. The advent of patient-derived organoid cultures (PDOs) has provided a breakthrough in personalised medicine, allowing researchers and clinicians to model the complexity and heterogeneity of individual tumours in vitro. PDOs hold great promise in this field, as variations in the management of peritoneal carcinomatosis due to differences in the method of delivery of chemotherapeutics, drug selection, exposure duration, and tumour pathology make it impractical to use a single, standardised treatment regimen. We aim to summarise the methodologies and limitations of studies encapsulating organoids derived from peritoneal metastases to encourage design considerations that may improve future clinical relevance, standardise protocols, and address translational challenges in personalising treatment strategies.

Förderung

  • Tour de Cure

Zitieren

APA

Kaur, H., Wright, J. A., Worthley, D. L., Murphy, E., & Woods, S. L. (2025). Precision Medicine for Peritoneal Carcinomatosis—Current Advances in Organoid Drug Testing and Clinical Applicability. Organoids, 4(1), 2. https://doi.org/10.3390/organoids4010002

Vancouver

Kaur H, Wright JA, Worthley DL, Murphy E, Woods SL. Precision Medicine for Peritoneal Carcinomatosis—Current Advances in Organoid Drug Testing and Clinical Applicability. Organoids. 2025;4(1):2. doi:10.3390/organoids4010002

BibTeX
@article{Kaur2025,
  author = {Kaur, Harleen and Wright, Josephine A. and Worthley, Daniel L. and Murphy, Elizabeth and Woods, Susan L.},
  title = {Precision Medicine for Peritoneal Carcinomatosis—Current Advances in Organoid Drug Testing and Clinical Applicability},
  journal = {Organoids},
  year = {2025},
  volume = {4},
  number = {1},
  pages = {2},
  doi = {10.3390/organoids4010002}
}
Kostenlos starten →